You are here: Industry Insights > Zika virus

News List

Zika virus vaccines global market expected to reach $18,697 million by 2022 pharmaasia
February 16, 2017
A new report published by Allied Market Research, titled, “Zika Virus Vaccines Market-Global Opportunity Analysis and Industry Forecast, 2017-2022”, projects that in moderate growth scenario the potential market for Zika virus vaccines would reach $14,500
NewLink Genetics selects Cevec’s CAP Technologies to develop Zika vaccine pharmaceutical-technology
February 13, 2017
German company Cevec Pharmaceuticals has signed an agreement with NewLink Genetics for the use of its CAPGT and CAPGo cell lines in the development and commercialisation of products to treat Zika virus infections.
FDA approves Abbott’s molecular Zika virus test europeanpharmaceuticalreview
February 06, 2017
The US Food and Drug Administration (FDA) has authorised Abbott’s molecular test to detect Zika virus in whole blood (when collected alongside a patient-matched serum or plasma sample) for emergency use.
FDA Grants Abbott the First Commercial Authorization for a Molecular Test to Detect Zika Virus Using americanpharmaceuticalreview
February 06, 2017
Abbott has announced that the U.S. Food and Drug Administration (FDA) has authorized its molecular test, the Abbott RealTime ZIKA test, to detect Zika virus in whole blood (when collected alongside a patient-matched serum or plasma sample) for emergency u
New Zika virus monoclonal antibodies pharmaasia
January 16, 2017
Maine’s biotech company, ViroStat Inc, has come up with a new set of monoclonal antibodies to the NS1 protein of the Zika virus.

Previous page 1 2 Next page